AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Sitacose M 50mg/850mg Tablet

Prescription Icon
Prescription Required

Marketer

J B Chemicals and Pharmaceuticals Ltd

Salt Composition

Sitagliptin (50mg) + Metformin (850mg)

Overview Sitacose M 50mg/850mg Tablet

Diabetace Duo 50mg/850mg tablets combine two medications to manage elevated blood glucose in individuals with type 2 diabetes. This dual action helps prevent serious diabetic complications like renal impairment and vision loss, potentially lowering the risk of cardiovascular events. Diabetace Duo may be used independently or in conjunction with other antidiabetic therapies. Optimal results are achieved with a balanced diet and regular physical activity. Dosage is personalized based on your health status, glucose levels, and other medications. Taking it with food minimizes gastrointestinal discomfort. Consistent daily dosing at the same time maximizes effectiveness; discontinuation should only occur under medical guidance. Adherence to the prescribed diet and exercise plan is crucial for diabetes control, as lifestyle significantly impacts management. Common side effects include nausea, vomiting, diarrhea, stomach upset, headache, and sore throat. Low blood sugar (hypoglycemia) is a potential risk, particularly when used with insulin or sulfonylureas; learn to recognize and address this. This medication isn't universally suitable. Inform your doctor about any pre-existing kidney, liver, heart, or pancreatic conditions, or excessive alcohol consumption before starting. Pregnant or lactating individuals should seek medical counsel. Interactions with other medications are possible; disclose all your medications to ensure safety. Alcohol should be minimized due to its blood glucose-lowering effect. Kidney function and blood sugar levels will be monitored by your physician throughout treatment.

Uses of Sitacose M 50mg/850mg Tablet

Managing type 2 diabetes

Major Benefits of Sitacose M 50mg/850mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Sitacose M 50mg/850mg tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.

Common Side effects of Sitacose M 50mg/850mg Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Sitacose M 50mg/850mg Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Sitacose M 50mg/850mg tablets should be administered with a meal.

How Sitacose M 50mg/850mg Tablet works:

Sitacose M, a 50mg/850mg tablet, combines sitagliptin and metformin to manage blood glucose levels. Sitagliptin enhances insulin production by the pancreas, improves insulin utilization, and decreases hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and increases insulin sensitivity. This dual action leads to superior glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Sitacose M 50mg/850mg tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Sitacose M 50mg/850mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any possible risks prior to prescription. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Sitacose M 50mg/850mg tablets while breastfeeding is likely inadvisable. Preliminary human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Individuals with impaired kidney function should use Sitacose M 50mg/850mg tablets cautiously, potentially requiring dosage modification under medical supervision. The medication is contraindicated in patients with severe kidney disease. Routine monitoring of kidney function is recommended during treatment.

LiverLiverUNSAFE

Patients with liver impairment should likely abstain from Sitacose M 50mg/850mg Tablets due to potential safety concerns. Medical advice is recommended.

What if you forget to take Sitacose M 50mg/850mg Tablet :

Should you forget a dose of Sitacose M 50mg/850mg Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Sitacose M 50mg/850mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Treatment

FAQs on Sitacose M 50mg/850mg Tablet

Sitacose M 50mg/850mg tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Prolonged use of Sitacose M 50mg/850mg Tablets can lead to vitamin B12 deficiency by impairing its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), and urinary issues, potentially impacting mental state. To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Sitacose M 50mg/850mg tablets may cause common side effects such as low blood sugar (hypoglycemia), taste changes, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Sitacose M 50mg/850mg Tablets are contraindicated in patients with known allergies to any ingredient or excipient. Avoid use in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitacose M 50mg/850mg tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Store this medication in its original, tightly closed container, as directed on the label. Dispose of any unused medication properly and ensure it remains inaccessible to children, pets, and others.
Sitagliptin + Metformin (like Sitacose M 50mg/850mg) can rarely cause lactic acidosis (MALA), a serious medical emergency involving high blood lactic acid levels. This risk is higher in patients with kidney disease, older adults, and heavy alcohol users. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, stop taking the medication and seek immediate medical attention.
Sitacose M 50mg/850mg tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This medication improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Sitacose M 50mg/850mg tablets may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Sitacose M 50mg/850mg Tablets are contraindicated in patients with known allergies to any ingredient or excipient. Avoid use in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitacose M 50mg/850mg tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Sitagliptin/Metformin 50mg/850mg tablets can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA—Metformin-associated lactic acidosis). While rare, this risk is heightened in patients with kidney disease, the elderly, or those consuming large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitagliptin/Metformin immediately and seek urgent medical attention.
Prolonged use of Sitacose M 50mg/850mg tablets can lead to vitamin B12 deficiency by impairing its absorption. This deficiency, if left untreated, may cause anemia, neurological issues such as numbness and tingling in the extremities, weakness, urinary problems, cognitive changes, and balance difficulties (ataxia). To mitigate this risk, annual supplemental vitamin B12 intake is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitacose M 50mg/850mg tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This medication improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Sitacose M 50mg/850mg Tablets may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Sitacose M 50mg/850mg Tablets are contraindicated in patients with known allergies to any ingredient or excipient. Avoid use in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitacose M 50mg/850mg tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Sitagliptin/Metformin (like Sitacose M 50mg/850mg) can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as Metformin-Associated Lactic Acidosis or MALA). While rare, this risk is higher in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If experienced, discontinue Sitagliptin/Metformin immediately and seek urgent medical attention.
Prolonged use of Sitacose M 50mg/850mg tablets can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and balance problems), if left unaddressed. To mitigate this risk, annual supplemental vitamin B12 intake is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitacose M 50mg/850mg Tab...
103
MRP 120
14% off